Uwe Platzbecker

Uwe Platzbecker at Leipzig University Hospital is a leading European MDS specialist who was a principal investigator of the MEDALIST trial establishing luspatercept (erythroid maturation agent targeting TGF-beta superfamily) as standard of care for transfusion-dependent lower-risk MDS with ring sideroblasts. His research on improving anemia management in MDS and reducing transfusion burden has direct patient quality-of-life benefits.